Kidney stress is often silent compared to other organs From foamy urine to fatigue our expert shares the vital questions and subtle signs to help you assess your kidney health ...

Novartis NOVN1.01%increase; green up pointing triangle said its Vanrafia drug slows the decline in kidney function for adults with the progressive autoimmune kidney disease, IgA nephropathy (IgAN).

IgA nephropathy, first described in 1968 by Berger and Hinglais, 1 is the most common form of primary glomerulonephritis. For decades, IgA nephropathy was considered to have a relatively good ...

Explore KDIGO 2025 IgA nephropathy shifts: treat earlier at proteinuria >0.5 g/day, dual-pathway therapy aims to preserve GFR. Welcome back to another AJMC Insights series. In this episode titled, ...

Dr Shikha Wadhwani emphasizes that this is an important time for nephrology: Better‑tolerated, more effective therapies for immunoglobulin (Ig)A nephropathy are now available. Her key advice to ...

Robert Burakoff, MD, MPH, is a board-certified gastroenterologist who serves as vice chair of Ambulatory Services at Lower Manhattan Hospital and professor of medicine at the Weill Cornell Medical ...

Gaia Coppock, MD, examines why the rapidly evolving treatment landscape for IgA nephropathy can be overwhelming for nephrologists, who face challenges in selecting the best therapies amid frequent ...

Please provide your email address to receive an email when new articles are posted on . Sibeprenlimab-szsi is the first approved A-proliferation-inducing-ligand blocker for adults with IgA nephropathy ...

Dr Dana Rizk discusses Voyxact (sibeprenlimab-szsi), a new FDA-approved treatment to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. Dr ...

In the final analysis, iptacopan was found to statistically significantly slow IgAN progression compared with placebo. Final results were announced from the phase 3 APPLAUSE-IgAN trial evaluating ...

Source: Getty Images KDIGO’s new guideline on IgA nephropathy highlights its immunologic pathophysiology and encourages early diagnosis and management to prevent or delay end-stage kidney disease.

For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...